RepliCel Historical Financial Ratios

RP Stock  CAD 0.01  0.01  50.00%   
RepliCel Life is promptly reporting on over 87 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Average Payables of 274.5 K, Stock Based Compensation To Revenue of 0.72, Capex To Depreciation of 0.0022 or Ev To Sales of 20.41 will help investors to properly organize and evaluate RepliCel Life Sciences financial condition quickly.
Quick RatioCurrent Ratio
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About RepliCel Financial Ratios Analysis

RepliCel Life SciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate RepliCel Life investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on RepliCel financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across RepliCel Life history.

RepliCel Life Financial Ratios Chart

At this time, RepliCel Life's Invested Capital is fairly stable compared to the past year. Stock Based Compensation To Revenue is likely to climb to 0.72 in 2024, despite the fact that PTB Ratio is likely to grow to (0.81).
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing RepliCel Life Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on RepliCel Life sales, a figure that is much harder to manipulate than other RepliCel Life Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.
Most ratios from RepliCel Life's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into RepliCel Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, RepliCel Life's Invested Capital is fairly stable compared to the past year. Stock Based Compensation To Revenue is likely to climb to 0.72 in 2024, despite the fact that PTB Ratio is likely to grow to (0.81).
 2021 2022 2023 2024 (projected)
Graham Number0.770.260.09520.0904
Receivables Turnover5.784.310.09.5

RepliCel Life fundamentals Correlations

-0.230.990.23-0.320.26-0.36-0.19-0.33-0.230.98-0.360.31-0.39-0.540.210.170.070.220.16-0.190.130.310.190.29-0.2
-0.23-0.250.050.150.23-0.36-0.150.181.0-0.27-0.36-0.98-0.360.40.040.20.050.20.2-0.20.02-0.980.20.08-0.16
0.99-0.250.19-0.370.29-0.32-0.13-0.38-0.250.97-0.320.34-0.35-0.60.170.190.10.240.18-0.210.170.330.210.32-0.14
0.230.050.190.30.05-0.39-0.530.460.050.16-0.39-0.06-0.450.40.940.130.310.080.15-0.01-0.54-0.060.13-0.520.34
-0.320.15-0.370.3-0.360.06-0.230.620.15-0.390.06-0.25-0.010.630.37-0.330.09-0.34-0.320.4-0.48-0.24-0.33-0.480.16
0.260.230.290.05-0.36-0.230.42-0.690.230.3-0.22-0.07-0.24-0.430.210.98-0.090.990.97-0.97-0.05-0.080.980.090.12
-0.36-0.36-0.32-0.390.06-0.230.38-0.29-0.36-0.291.00.340.99-0.16-0.3-0.15-0.14-0.14-0.140.15-0.210.34-0.15-0.340.48
-0.19-0.15-0.13-0.53-0.230.420.38-0.6-0.15-0.130.380.20.4-0.52-0.280.4-0.490.420.39-0.40.080.20.40.150.11
-0.330.18-0.380.460.62-0.69-0.29-0.60.18-0.43-0.29-0.31-0.310.850.34-0.640.18-0.69-0.630.73-0.27-0.31-0.65-0.32-0.14
-0.231.0-0.250.050.150.23-0.36-0.150.18-0.27-0.36-0.98-0.360.40.040.20.050.20.2-0.20.02-0.980.20.08-0.16
0.98-0.270.970.16-0.390.3-0.29-0.13-0.43-0.27-0.290.36-0.32-0.640.130.210.040.260.2-0.250.210.350.220.34-0.17
-0.36-0.36-0.32-0.390.06-0.221.00.38-0.29-0.36-0.290.340.99-0.17-0.31-0.15-0.14-0.14-0.140.15-0.210.34-0.15-0.340.48
0.31-0.980.34-0.06-0.25-0.070.340.2-0.31-0.980.360.340.34-0.49-0.04-0.05-0.06-0.04-0.040.05-0.041.0-0.05-0.070.14
-0.39-0.36-0.35-0.45-0.01-0.240.990.4-0.31-0.36-0.320.990.34-0.19-0.38-0.16-0.13-0.15-0.160.15-0.130.34-0.17-0.270.46
-0.540.4-0.60.40.63-0.43-0.16-0.520.850.4-0.64-0.17-0.49-0.190.32-0.350.16-0.41-0.330.47-0.48-0.48-0.36-0.52-0.07
0.210.040.170.940.370.21-0.3-0.280.340.040.13-0.31-0.04-0.380.320.30.160.240.31-0.14-0.68-0.030.29-0.610.37
0.170.20.190.13-0.330.98-0.150.4-0.640.20.21-0.15-0.05-0.16-0.350.3-0.080.991.0-0.96-0.2-0.051.0-0.10.19
0.070.050.10.310.09-0.09-0.14-0.490.180.050.04-0.14-0.06-0.130.160.16-0.08-0.08-0.080.06-0.02-0.06-0.08-0.080.23
0.220.20.240.08-0.340.99-0.140.42-0.690.20.26-0.14-0.04-0.15-0.410.240.99-0.080.99-0.98-0.13-0.041.0-0.020.19
0.160.20.180.15-0.320.97-0.140.39-0.630.20.2-0.14-0.04-0.16-0.330.311.0-0.080.99-0.96-0.22-0.041.0-0.130.2
-0.19-0.2-0.21-0.010.4-0.970.15-0.40.73-0.2-0.250.150.050.150.47-0.14-0.960.06-0.98-0.96-0.040.05-0.97-0.11-0.2
0.130.020.17-0.54-0.48-0.05-0.210.08-0.270.020.21-0.21-0.04-0.13-0.48-0.68-0.2-0.02-0.13-0.22-0.04-0.04-0.180.95-0.22
0.31-0.980.33-0.06-0.24-0.080.340.2-0.31-0.980.350.341.00.34-0.48-0.03-0.05-0.06-0.04-0.040.05-0.04-0.05-0.070.15
0.190.20.210.13-0.330.98-0.150.4-0.650.20.22-0.15-0.05-0.17-0.360.291.0-0.081.01.0-0.97-0.18-0.05-0.080.19
0.290.080.32-0.52-0.480.09-0.340.15-0.320.080.34-0.34-0.07-0.27-0.52-0.61-0.1-0.08-0.02-0.13-0.110.95-0.07-0.08-0.33
-0.2-0.16-0.140.340.160.120.480.11-0.14-0.16-0.170.480.140.46-0.070.370.190.230.190.2-0.2-0.220.150.19-0.33
Click cells to compare fundamentals

RepliCel Life Account Relationship Matchups

RepliCel Life fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio17.3817.5321.129.0810.8910.34
Ptb Ratio(1.39)(1.23)(1.09)(0.54)(0.85)(0.81)
Days Sales Outstanding53.5565.6463.1984.7936.534.68
Book Value Per Share(0.18)(0.19)(0.21)(0.16)(0.0765)(0.0803)
Free Cash Flow Yield(0.45)(0.12)(0.34)(0.44)(0.37)(0.39)
Operating Cash Flow Per Share(0.12)(0.0284)(0.0774)(0.0373)(0.0239)(0.0251)
Average Payables595.7K848.5K829.4K709.9K482.9K274.5K
Pb Ratio(1.39)(1.23)(1.09)(0.54)(0.85)(0.81)
Ev To Sales18.5817.6520.598.0213.1920.41
Free Cash Flow Per Share(0.12)(0.0284)(0.0774)(0.0373)(0.0239)(0.0251)
Roic6.020.740.290.40.09690.38
Net Income Per Share(0.13)(0.12)(0.0586)(0.0197)(0.005262)(0.005525)
Sales General And Administrative To Revenue3.072.54.263.183.435.46
Research And Ddevelopement To Revenue6.212.323.251.761.491.41
Cash Per Share0.0021850.0019140.007340.01140.001290.001225
Pocfratio(2.21)(8.1)(2.97)(2.28)(2.72)(2.86)
Pfcf Ratio(2.21)(8.1)(2.97)(2.28)(2.72)(2.86)
Income Quality0.930.480.621.94.544.76
Roe0.680.310.60.130.06880.0722
Ev To Operating Cash Flow(2.36)(8.16)(2.9)(2.01)(3.3)(3.46)
Pe Ratio(2.05)(3.92)(1.83)(4.32)(12.35)(12.97)
Return On Tangible Assets(5.94)(3.75)(6.88)(0.93)(1.08)(1.14)
Ev To Free Cash Flow(2.36)(8.16)(2.9)(2.01)(3.3)(3.46)
Earnings Yield(0.49)(0.25)(0.55)(0.23)(0.081)(0.085)
Net Debt To E B I T D A(0.14)(0.0276)0.04760.56(0.59)(0.62)
Current Ratio0.150.08290.230.310.08890.0845
Tangible Book Value Per Share(0.18)(0.19)(0.21)(0.16)(0.0765)(0.0803)
Receivables Turnover6.825.565.784.310.09.5
Graham Number0.720.50.770.260.09520.0904
Shareholders Equity Per Share(0.18)(0.19)(0.21)(0.16)(0.0765)(0.0803)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for RepliCel Stock Analysis

When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…